公司問答丨廈門信達:公司信達物聯業務板塊在國防動員領域實現技術突破
格隆匯6月25日丨有投資者在互動平台向廈門信達公司提問:近聞,遼寧省軍區朝陽軍分區人武部一行到訪廈門信達股份有限公司,雙方就“智慧國防”項目推進情況進行了交流。請公司就涉及軍工方面的業務以及“智慧國防”的項目情況,做一個簡單的介紹。廈門信達迴應:公司信達物聯業務板塊在國防動員領域實現技術突破,推出“智慧國防”應用場景項目,自主研發搭建了國防動員協同指揮系統。該系統上線運營後可實現國防動員一體化、信息化與智能化,通過融合大數據、雲計算、物聯網等信息技術,與地方公安、應急、人防、氣象等專項指揮平台聯通,有效整合人員、車輛、裝備等綜合數據,實現國防信息數據的統一管理、動員調度和應急指揮。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.